From: Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience
Variables | NET G1 (n = 39, %) | NET G2 (n = 7, %) | NEC G3 (n = 69, %) | MANEC (n = 20, %) | P value |
---|---|---|---|---|---|
Depth of invasion | <0.001 | ||||
T1 | 29 (74.4) | 3 (42.9) | 4 (5.8) | 1 (5.0) | |
T2 | 7 (17.9) | 0 (0.0) | 6 (8.7) | 3 (15.0) | |
T3 | 2 (5.1) | 0 (0.0) | 23 (33.3) | 9 (45.0) | |
T4 | 1 (2.6) | 4 (57.1) | 36 (52.2) | 7 (35.0) | |
Lymph node metastasis | <0.001 | ||||
N0 | 36 (92.3) | 3 (42.9) | 4 (5.8) | 3 (15.0) | |
N1 | 3 (7.7) | 4 (57.1) | 65 (94.2) | 17 (85.0) | |
Distant metastasis | 0.001 | ||||
M0 | 39 (100.0) | 5 (71.4) | 60 (87.0) | 14 (70.0) | |
M1 | 0 (0.0) | 2 (28.6) | 9 (13.0) | 6 (30.0) | |
TNM stage | <0.001 | ||||
I/II | 36 (92.3) | 3 (42.9) | 4 (5.8) | 2 (10.0) | |
III/IV | 3 (7.7) | 4 (57.1) | 65 (94.2) | 18 (90.0) | |
Vascular invasion | 0 (0.0) | 2 (28.6) | 33 (47.8) | 8 (40.0) | <0.001 |
Immunohistochemical features | |||||
CgA (+) | 32 (82.1) | 4 (57.1) | 57 (82.6) | 15 (75.0) | 0.367 |
Syn (+) | 29 (74.4) | 5 (71.4) | 53 (76.8) | 13 (65.0) | 0.728 |
NSE (+) | 9 (23.1) | 2 (28.6) | 16 (23.2) | 2 (10.0) | 0.594 |
CD56 (+) | 16 (41.0) | 4 (57.1) | 38 (55.1) | 5 (25.0) | 0.086 |